## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.3% in lower entry zone (4.0-10.0%), top quartile (81st pct) cross-sectional ranking. Short-term MRS_5 (2.4%) confirms momentum alignment. Strong momentum (+1.3% 5-day acceleration). Outperforming sector by 5.7%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($23.22)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 3, Bearish: 0)

**1. HORMEL FOODS CORP /DE/ SEC 10-K Report**
- Source: TradingView | 20251205T210810 | Somewhat-Bearish | Relevance: 100%
- Hormel Foods Corporation has released its Form 10-K report for fiscal 2025, detailing its financial performance, operations, and strategic initiatives. The company reported a net sales increase of 1.6% but a significant decline in operating income and net earnings due to non-cash impairment charges. Hormel plans to focus on organic net sales growth, continued investment in its T&M initiative, and capital management for fiscal 2026, while navigating competitive and economic challenges.

**2. Hormel wants to make meals easier with Jennie-O, Applegate**
- Source: WATTPoultry.com | 20251205T203303 | Bullish | Relevance: 100%
- Hormel Foods aims to simplify meal preparation by leveraging its Jennie-O and Applegate brands. The company plans to introduce innovative turkey products and expand into chicken categories like quick-prep breakfast and easy dinner options to meet consumer demand for convenient, healthy meals. This strategy is driven by consumer insights indicating a struggle to find such options, contributing to increased retail and foodservice sales for Hormel in Q4 2025.

**3. Hormel Foods Corporation (NYSE:HRL) Q4 2025 Earnings Call Transcript**
- Source: Insider Monkey | 20251205T130806 | Somewhat-Bullish | Relevance: 100%
- Hormel Foods Corporation reported Q4 2025 earnings where reported EPS was $0.32, beating expectations of $0.3017. Despite a challenging year with elevated input costs and unforeseen setbacks, net sales exceeded $12 billion, showing 2% organic growth across all three segments. The company provided a fiscal 2026 outlook, expecting 1% to 4% organic net sales growth and adjusted EPS in the range of $1.43 to $1.51, focusing on strategic priorities, brand investment, and cost management.

**4. Hormel Foods (NYSE:HRL) Misses Q3 CY2025 Revenue Estimates**
- Source: The Globe and Mail | 20251205T030825 | Somewhat-Bearish | Relevance: 100%
- Hormel Foods (NYSE:HRL) reported Q3 CY2025 revenue of $3.19 billion, falling short of analyst estimates despite a 1.5% year-on-year increase. While revenue missed targets, the company's non-GAAP profit of $0.32 per share exceeded consensus estimates by 6%, and its full-year revenue outlook was close to analyst predictions. The company continues to face challenges with sales volume, which decreased by 1.8% year-on-year in Q3.

**5. Hormel Foods (HRL) Q3 EPS Gain Tests Bullish Margin Expansion Narrative**
- Source: Simply Wall Street | 20251205T000320 | Somewhat-Bearish | Relevance: 100%
- Hormel Foods (HRL) reported Q3 2025 results with revenues of $3.0 billion and basic EPS of $0.33, indicating modest growth. Despite a stable top line, the company's net profit margin of 6.3% and a 4.4% annual decline in five-year earnings challenge the bullish narrative of margin expansion. The current valuation suggests potential upside based on discounted cash flow but also raises concerns due to its P/E ratio being higher than peers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |
| 2025-11-21 | JP Morgan | $27 | $30 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |
| 2025-11-21 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 12 ($0.26M) |
| Sells | 8 ($0.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Long-term trend broken: trading 11.9% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.3% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.66 elevated, pricing in significant growth expectations. Forward P/E 15.6x stretched relative to 6% growth. Balance sheet: strong liquidity (2.5x). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.3B |
| Beta | 0.33 |
| 52W Range | $21.03 - $32.07 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.66 |
| Forward P/E | 15.6 |
| Current P/E | 16.6 |
| YoY Growth | 6.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 3.0% to 4.3% (+1.3% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 81st percentile. MRS_5 at 2.4% confirms short-term momentum alignment. AM_20 at 6.7% shows strong absolute momentum above own 20MA. Outperforming sector by 5.7pp, stock-specific strength. Below SMA200 (0.88x), long-term trend not supportive. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +SBN (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.28% (CS: 82) | Strong |
| RSI_14 | 69.0 | Neutral |
| MACD Histogram | 0.25 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.048x | Above |
| vs SMA200 | 0.881x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $24.34
- **Stop Loss:** $23.22 (4.6% risk)
- **Target:** $26.02 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 446
- **Position Value:** $10,855.64
- **Portfolio %:** 10.86%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*